Validation and quality measurements for STS, EuroSCORE II and a regional risk model in Brazilian patients

Objectives The objectives of this study were to describe a novel statewide registry for cardiac surgery in Brazil (REPLICCAR), to compare a regional risk model (SPScore) with EuroSCORE II and STS, and to understand where quality improvement and safety initiatives can be implemented. Methods A total...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2020-09, Vol.15 (9), p.e0238737-e0238737
Hauptverfasser: Mejia, Omar Asdrubal Vilca, Borgomoni, Gabrielle Barbosa, Zubelli, Jorge Passamani, Dallan, Luís Roberto Palma, Pomerantzeff, Pablo Maria Alberto, Oliveira, Marco Antonio Praca, Petrucci Junior, Orlando, Tiveron, Marcos Gradim, Nakazone, Marcelo Arruda, Tineli, Rafael Angelo, Campagnucci, Valquíria Pelisser, Silva, Roberto Rocha e, Rodrigues, Alfredo Jose, Gomes, Walter Jose, Lisboa, Luiz Augusto Ferreira, Jatene, Fabio Biscegli
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives The objectives of this study were to describe a novel statewide registry for cardiac surgery in Brazil (REPLICCAR), to compare a regional risk model (SPScore) with EuroSCORE II and STS, and to understand where quality improvement and safety initiatives can be implemented. Methods A total of 11 sites in the state of São Paulo, Brazil, formed an online registry platform to capture information on risk factors and outcomes after cardiac surgery procedures for all consecutive patients. EuroSCORE II and STS values were calculated for each patient. An SPScore model was designed and compared with EuroSCORE II and STS to predict 30-day outcomes: death, reoperation, readmission, and any morbidity. Results A total of 5222 patients were enrolled in this study between November 2013 and December 2017. The observed 30-day mortality rate was 7.6%. Most patients were older, overweight, and classified as New York Heart Association (NYHA) functional class III; 14.5% of the patient population had a positive diagnosis of rheumatic heart disease, 10.9% had insulin-dependent diabetes, and 19 individuals had a positive diagnosis of Chagas disease. When evaluating the prediction performance, we found that SPScore outperformed EuroSCORE II and STS in the prediction of mortality (0.90 vs. 0.76 and 0.77), reoperation (0.84 vs. 0.60 and 0.56), readmission (0.84 vs. 0.55 and 0.51), and any morbidity (0.80 vs. 0.65 and 0.64), respectively (p
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0238737